Bioinspired nanoregulator triggers mitochondrial dysfunction in tumors, indicating precision oncology potential.
Disrupting mitochondrial calcium ion (Ca²⁺) homeostasis in tumor cells has emerged as a potent anticancer strategy, however, achieving precise, spatiotemporal control of mitochondrial Ca²⁺ overload poses a significant challenge. Herein, we present a bioinspired miRNA-responsive Ca²⁺ nanoregulator (Cu₂O@Dz) that orchestrates endogenous ion flux through a multistage cascade to induce tumor-specific mitochondrial dysfunction. In this design, hairpin-structured DNAzymes (Dz) are conjugated to cuprous oxide (Cu₂O) nanoparticles: within the acidic and H₂O₂-rich tumor microenvironment, the Cu₂O core catalyzes site-specific Fenton-like reactions to generate hydroxyl radicals (•OH), which activate TRPA1 channels on the cell membrane and thereby trigger a robust influx of extracellular Ca²⁺. Concurrently, the Dz component functions as a dual-mode biosensor-actuator: recognition of overexpressed miRNA-21 produces a fluorescent signal for real-time diagnosis monitoring, while cleavage of miRNA-25 alleviates suppression of the mitochondrial calcium uniporter (MCU), thereby promoting mitochondrial Ca²⁺ uptake. The synergistic coupling of a TRPA1-mediated cytosolic Ca²⁺ surge with MCU-driven mitochondrial import establishes a unidirectional Ca²⁺ gradient, culminating in irreversible mitochondrial Ca²⁺ overload and potent tumor cell apoptosis. This work not only demonstrates an efficiently spatiotemporal coordination of dual ion-interference pathways for precision targeting but also establishes a versatile framework for organelle specific modulation of pathological ion fluxes in precision oncology.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: